Literature DB >> 19827138

Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering.

Hanane A Dahoui1, Munya N Hayek, Paul J Nietert, Mariam T Arabi, Samar A Muwakkit, Raya H Saab, Abdallah N Bissar, Nidal M Jumaa, Fadi S Farhat, Ibrahim A Dabbous, Fadi F Bitar, Miguel R Abboud.   

Abstract

BACKGROUND: Pulmonary hypertension (PHTN) is increasingly recognized as a serious complication of sickle cell disease (SCD). Our objective was to determine the prevalence of PHTN and identify factors associated with PHTN among children and young adults with SCD in Lebanon. PROCEDURE: From June 2004 to June 2008, 90 patients were studied. Correlation of TRV with LDH, mean corpuscular volume (MCV), fetal hemoglobin (HbF), hydroxyurea use, and G6PD deficiency was performed. Transthoracic Doppler echocardiography was performed during steady-state at each patient's initial visit and yearly thereafter. PHT was defined as a tricuspid regurgitant jet velocity (TRV) > or =2.5 m/sec.
RESULTS: Twenty-seven patients (31.8%) were found to have PHTN. They had significantly higher LDH levels (P = 0.008) and MCV (P = 0.024). There was a higher percentage of patients on hydroxyurea in the group with PHTN (78% vs. 50%, P = 0.015). Furthermore, five children, mean age 9.8 years (range, 6-13 years), with initially normal TRV developed PHTN while on hydroxyurea for at least 3 years, at a mean dose of 19.2 mg/kg/day (range, 14-24). PHTN clustered in families and was found in all members with SCD in 7 of the 21 families studied; they contributed 16 of the 27 patients with PHTN. None of the 21 patients with PHTN were G6PD deficient compared to 4 of 36 without PHTN.
CONCLUSIONS: PHTN was common, associated with increased hemolysis but not G6PD deficiency, and clustered in families. Moreover, PHTN developed despite hydroxyurea therapy in five patients. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19827138     DOI: 10.1002/pbc.22306

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

1.  Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.

Authors:  Parul Rai; Vijaya M Joshi; Jason F Goldberg; Amber M Yates; Victoria I Okhomina; Rhiannon Penkert; Kenneth I Ataga; Guolian Kang; Jane S Hankins
Journal:  Blood Adv       Date:  2021-01-12

2.  Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia.

Authors:  Victor R Gordeuk; Caterina P Minniti; Mehdi Nouraie; Andrew D Campbell; Sohail R Rana; Lori Luchtman-Jones; Craig Sable; Niti Dham; Gregory Ensing; Josef T Prchal; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro
Journal:  Haematologica       Date:  2010-09-30       Impact factor: 9.941

3.  Hypoxic activation of glucose-6-phosphate dehydrogenase controls the expression of genes involved in the pathogenesis of pulmonary hypertension through the regulation of DNA methylation.

Authors:  Sachindra Raj Joshi; Atsushi Kitagawa; Christina Jacob; Ryota Hashimoto; Vidhi Dhagia; Amrit Ramesh; Connie Zheng; Hui Zhang; Allan Jordan; Ian Waddell; Jane Leopold; Cheng-Jun Hu; Ivan F McMurtry; Angelo D'Alessandro; Kurt R Stenmark; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

Review 4.  Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains.

Authors:  Miranda K Culley; Stephen Y Chan
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

Review 5.  How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders.

Authors:  Evans M Machogu; Roberto F Machado
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

6.  Doppler echocardiographic assessment of pulmonary artery pressure in children with sickle cell anaemia.

Authors:  Moriam Omolola Lamina; Barakat Adeola Animasahun; Ijeoma Nnena Akinwumi; Olisamedua Fidelis Njokanma
Journal:  Cardiovasc Diagn Ther       Date:  2019-06

Review 7.  Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.

Authors:  Angelo D'Alessandro; Karim C El Kasmi; Lydie Plecitá-Hlavatá; Petr Ježek; Min Li; Hui Zhang; Sachin A Gupte; Kurt R Stenmark
Journal:  Antioxid Redox Signal       Date:  2017-08-14       Impact factor: 8.401

8.  Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria.

Authors:  Ogochukwu J Sokunbi; Ekanem N Ekure; Edamisan O Temiye; Roosevelt Anyanwu; Christy A N Okoromah
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

Review 9.  Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.

Authors:  Giovanna Cannas; Solène Poutrel; Xavier Thomas
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-15       Impact factor: 2.576

10.  Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease.

Authors:  Isabelle Halphen; Caroline Elie; Valentine Brousse; Muriel Le Bourgeois; Slimane Allali; Damien Bonnet; Mariane de Montalembert
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.